European Phase II Trials of Nivolumab Plus Ipilimumab Immunotherapy Benefit Pleural ...
Medical Health News,
In the Lancet Respiratory Medicine and Lancet Oncology journals, respectively, results of Phase II immunotherapy trials in…
In the Lancet Respiratory Medicine and Lancet Oncology journals, respectively, results of Phase II immunotherapy trials in…
One of the prominent areas of mesothelioma research today is around the development of an effective, tolerable, second-line…
In a French phase II trial reported in The Lancet Oncology, Scherpereel et al found evidence of activity with nivolumab or the…